Sep 20, 2021

Last year, we began a video series featuring Richard Saynor listening to patient advocacy leaders from across the world. Topics of conversation included the impact of the pandemic on patients, engagement opportunities, biosimilars and more!

Now you can watch a series featuring Pierre Bourdage, Global Head of Biopharmaceuticals, Sandoz, in conversation with Zorana Maravic, CEO of Digestive Cancers Europe (DiCE). Pierre learns more on the patient community’s perspective on the impact of COVID-19 pandemic, future opportunities to transform cancer care for patients, the patient community’s perspective on access and biosimilars, and partnership opportunities between patient organizations and pharmaceutical companies to improve patient care.

Curious? Watch the conversation below

Part 1

Part 2

Part 3